NCT04407156 is a clinical trial of acute kidney injury in COVID, sponsored by University Hospitals of Derby and Burton NHS Foundation Trust.

Who is sponsoring NCT04407156?

NCT04407156 is sponsored by University Hospitals of Derby and Burton NHS Foundation Trust.

What drugs are being tested in NCT04407156?

Interventions in NCT04407156: acute kidney injury.

What condition does NCT04407156 study?

NCT04407156 studies COVID, AKI.

Is NCT04407156 still recruiting?

NCT04407156 is currently completed. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT04407156

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom

Completed Last updated 9 September 2020

What this trial tests

trial testing acute kidney injury in COVID in 724 participants. Completed in 20 July 2020.

Timeline

1 June 2020

Primary endpoint
7 June 2020

20 July 2020

Quick facts

Lead sponsor	University Hospitals of Derby and Burton NHS Foundation Trust
Status	Completed
Study type	OBSERVATIONAL
Enrollment	724
Start date	1 June 2020
Primary completion	7 June 2020
Estimated completion	20 July 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

acute kidney injury

Conditions studied

COVID — all drugs for COVID →
AKI — all drugs for AKI →

Sponsor

University Hospitals of Derby and Burton NHS Foundation Trust

Who can join

Adults 18 to 110, any sex, with COVID or AKI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Severe Acute respiratory syndrome coronovirus (SARS-CoV-2) was first described in Wuhan in December 2019. It quickly spread to rest of the world and was declared pandemic by World health organisation. Initial case series focused on lung involvement in the form alveolar haemorrhages and respiratory failure. However, subsequently, there have been reports of kidney involvement resulting in severe acute kidney injury. However, the reported incidence from Chinese data has been less than 5% and detailed epidemiology of AKI in COVID-19 disease is lacking.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acute kidney injury associated with COVID-19: A retrospective cohort study.
Kolhe NV, Fluck RJ, Selby NM, Taal MW. · · 2020 · cited 102× · PMID 33125416 · DOI 10.1371/journal.pmed.1003406

Verify or expand the search:

Other trials of acute kidney injury

Trials testing the same drug.

NCT06296108 — Risk Factors for Acute Kidney Injury in Patients Undergoing Arthroplasty · completed

Other recruiting trials for COVID

Currently open trials in the same condition.

NCT06744660 — Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test · NA · recruiting
NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
NCT04447833 — Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome · Phase 1 · active not recruiting
NCT04351347 — The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment · Phase 2, PHASE3 · recruiting
NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting

Other University Hospitals of Derby and Burton NHS Foundation Trust trials

Trials by the same sponsor.

NCT07377500 — Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis · NA · not yet recruiting
NCT07205692 — Multimorbidity and Cardiovascular Risk Factors After Renal Transplant · recruiting
NCT06109662 — Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease · active not recruiting
NCT06259305 — Memories in Heartbeats Study · NA · completed
NCT06284044 — Facilitating Safe Transition to Home for Preterm Infants - a National Database Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04407156 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospitals of Derby and Burton NHS Foundation Trust
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing